Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11290	Companies
250875	Keywords
179702	Articles
136711	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 08/10/2026 at 07:00, 2 months 27 days ago

Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Biophytis annonce l'autorisation de l'étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l'obésité. Démarrage de l'étude OBA dans une zone stratégique avec forte prévalence de l'obésité

Biophytis Étude Clinique BIO101 Obésité OBA
REGULATED PRESS RELEASE

published on 08/10/2026 at 07:00, 2 months 27 days ago

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Biophytis secures approval from ANVISA for OBA clinical trial in Brazil, advancing BIO101 drug candidate for obesity treatment. Key milestone in multinational clinical development

Biophytis Obesity Treatment OBA Clinical Trial ANVISA Approval BIO101 Drug Candidate
BRIEF

published on 08/03/2026 at 07:05, 3 months 3 days ago

Biophytis Updates on Hong Kong Joint Venture Progress

Biophytis Joint Venture Clinical Trial Sarcopenia BIO101
BRIEF

published on 08/03/2026 at 07:05, 3 months 3 days ago

Biophytis : Perspectives de sa Co-entreprise à Hong Kong

Biophytis Financement Sarcopénie Phase 3 Co-entreprise
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 3 months 3 days ago

Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Biophytis présente les avancées de sa co-entreprise à Hong Kong et ses perspectives de développement à court et moyen terme dans le domaine de la longévité

Biophytis Développement Hong Kong Sarcopénie Co-entreprise
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 3 months 3 days ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including intellectual property transfer, funding details, and clinical trial preparations

Biophytis Joint Venture Hong Kong Intellectual Property Clinical Trial
PRESS RELEASE

published on 08/03/2026 at 06:59, 3 months 3 days ago

Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Biophytis fait un point d'étape sur sa co-entreprise à Hong Kong et partage ses perspectives à court et moyen terme, notamment le déploiement de BIO101 et la phase 3 dans la sarcopénie

Biophytis Hong Kong Sarcopénie BIO101 Co-entreprise
PRESS RELEASE

published on 08/03/2026 at 06:59, 3 months 3 days ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including key milestones achieved and imminent progress. The joint venture aims to develop BIO101 for sarcopenia in Asian markets

Biophytis Joint Venture Hong Kong Sarcopenia BIO101
BRIEF

published on 07/29/2026 at 23:05, 3 months 7 days ago

Biophytis Reports Audited 2025 Financial Results and Stock Trading Resumption

Financial Results Biophytis Trading Resumption 2025 Audit Funding Uncertainty
BRIEF

published on 07/29/2026 at 23:05, 3 months 7 days ago

Biophytis : Publication des comptes annuels 2025 et reprise de la cotation

Biophytis Trésorerie Cotation Boursière Incertitude Financière Résultats Financiers 2025

Accesswire

Published on 11/06/2026 at 05:15, 4 hours 21 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 01:20, 8 hours 16 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 8 hours 43 minutes ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 8 hours 51 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 9 hours 41 minutes ago

Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 09:10, 26 minutes ago

Rentschler Biopharma Receives the Business Medal of the State of Baden-Wuerttemberg
Published on 11/06/2026 at 09:04, 31 minutes ago

PARMANTIER & CIE. appoints Stefan Heieck and Harry Tyser as Senior Advisors
Published on 11/06/2026 at 09:01, 35 minutes ago

Original-Research: Nynomic AG (von NuWays AG): BUY
Published on 11/06/2026 at 09:00, 36 minutes ago

Nexum Group Listing – Trading on the Frankfurt Stock Exchange's Regulated Market has begun
Published on 11/06/2026 at 09:00, 36 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 11/06/2026 at 09:07, 29 minutes ago

Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 31 minutes ago

Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 15 hours 14 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 15 hours 14 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 15 hours 35 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026

View all LES ECHOS COMFI WIRE